These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
578 related articles for article (PubMed ID: 30685678)
21. Statin exposure and risk of cancer in people with and without HIV infection. Bedimo RJ; Park LS; Shebl FM; Sigel K; Rentsch CT; Crothers K; Rodriguez-Barradas MC; Goetz MB; Butt AA; Brown ST; Gibert C; Justice AC; Tate JP AIDS; 2021 Feb; 35(2):325-334. PubMed ID: 33181533 [TBL] [Abstract][Full Text] [Related]
22. Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study. Clement ME; Park LP; Navar AM; Okeke NL; Pencina MJ; Douglas PS; Naggie S Clin Infect Dis; 2016 Aug; 63(3):407-13. PubMed ID: 27143663 [TBL] [Abstract][Full Text] [Related]
23. Statins Utilization in Adults With HIV: The Treatment Gap and Predictors of Statin Initiation. Coburn SB; Lang R; Zhang J; Palella FJ; Horberg MA; Castillo-Mancilla J; Gebo K; Galaviz KI; Gill MJ; Silverberg MJ; Hulgan T; Elion RA; Justice AC; Moore RD; Althoff KN; J Acquir Immune Defic Syndr; 2022 Dec; 91(5):469-478. PubMed ID: 36053091 [TBL] [Abstract][Full Text] [Related]
24. Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics Approach. deFilippi C; Toribio M; Wong LP; Sadreyev R; Grundberg I; Fitch KV; Zanni MV; Lo J; Sponseller CA; Sprecher E; Rashidi N; Thompson MA; Cagliero D; Aberg JA; Braun LR; Stanley TL; Lee H; Grinspoon SK J Infect Dis; 2020 Aug; 222(6):929-939. PubMed ID: 32310273 [TBL] [Abstract][Full Text] [Related]
25. Statin Eligibility and Prescribing Across Racial, Ethnic, and Language Groups over the 2013 ACC/AHA Guideline Change: a Retrospective Cohort Analysis from 2009 to 2018. Heintzman J; Kaufmann J; Rodriguez CJ; Lucas JA; Boston D; April-Sanders AK; Chung-Bridges K; Marino M J Gen Intern Med; 2023 Oct; 38(13):2970-2979. PubMed ID: 36977971 [TBL] [Abstract][Full Text] [Related]
26. Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012-2018). Liu Y; Lv X; Xie N; Fang Z; Ren W; Gong Y; Jin Y; Zhang J BMC Cardiovasc Disord; 2020 Apr; 20(1):201. PubMed ID: 32334525 [TBL] [Abstract][Full Text] [Related]
27. Statin use and lipid levels in older adults: National Health and Nutrition Examination Survey, 2001 to 2006. Robinson JG; Booth B J Clin Lipidol; 2010; 4(6):483-90. PubMed ID: 21122695 [TBL] [Abstract][Full Text] [Related]
28. Intensive statin regimens for reducing risk of cardiovascular diseases among human immunodeficiency virus-infected population: A nation-wide longitudinal cohort study 2000-2011. Ou HT; Chang KC; Li CY; Yang CY; Ko NY Int J Cardiol; 2017 Mar; 230():592-598. PubMed ID: 28062146 [TBL] [Abstract][Full Text] [Related]
29. Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study. Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS Curr Med Res Opin; 2008 Jul; 24(7):1987-2000. PubMed ID: 18554430 [TBL] [Abstract][Full Text] [Related]
31. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry. Nanna MG; Navar AM; Wang TY; Mi X; Virani SS; Louie MJ; Lee LV; Goldberg AC; Roger VL; Robinson J; Peterson ED J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29739801 [TBL] [Abstract][Full Text] [Related]
32. A Systematic Review and Meta-Analysis on the Impact of Statin Treatment in HIV Patients on Antiretroviral Therapy. Mokgalaboni K; Phoswa WN; Yates S; Lebelo SL; Madiba S; Modjadji P Int J Environ Res Public Health; 2023 Apr; 20(9):. PubMed ID: 37174188 [TBL] [Abstract][Full Text] [Related]
33. Statins for primary cardiovascular disease prevention among people with HIV: emergent directions. Fitch KV; Fulda ES; Grinspoon SK Curr Opin HIV AIDS; 2022 Sep; 17(5):293-300. PubMed ID: 35938463 [TBL] [Abstract][Full Text] [Related]
34. Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). Grinspoon SK; Fitch KV; Overton ET; Fichtenbaum CJ; Zanni MV; Aberg JA; Malvestutto C; Lu MT; Currier JS; Sponseller CA; Waclawiw M; Alston-Smith B; Cooper-Arnold K; Klingman KL; Desvigne-Nickens P; Hoffmann U; Ribaudo HJ; Douglas PS; Am Heart J; 2019 Jun; 212():23-35. PubMed ID: 30928825 [TBL] [Abstract][Full Text] [Related]
35. Comparison of statins for primary prevention of cardiovascular disease and persistent physical disability in older adults. Zhou Z; Curtis AJ; Ernst ME; Ryan J; Zoungas S; Wolfe R; McNeil JJ; Murray AM; Reid CM; Chowdhury EK; Woods RL; Tonkin AM; Nelson MR Eur J Clin Pharmacol; 2022 Mar; 78(3):467-476. PubMed ID: 34698889 [TBL] [Abstract][Full Text] [Related]
36. Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Walther CP; Richardson PA; Virani SS; Winkelmayer WC; Navaneethan SD Nephrol Dial Transplant; 2020 Feb; 35(2):312-319. PubMed ID: 30053252 [TBL] [Abstract][Full Text] [Related]
37. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study. Bang CN; Gislason GH; Greve AM; Torp-Pedersen C; Køber L; Wachtell K Eur J Prev Cardiol; 2014 Mar; 21(3):330-8. PubMed ID: 23012689 [TBL] [Abstract][Full Text] [Related]
38. Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trial. Baker JV; Huppler Hullsiek K; Prosser R; Duprez D; Grimm R; Tracy RP; Rhame F; Henry K; Neaton JD PLoS One; 2012; 7(10):e46894. PubMed ID: 23082133 [TBL] [Abstract][Full Text] [Related]
39. Vulnerabilities to Health Disparities and Statin Use in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Schroff P; Gamboa CM; Durant RW; Oikeh A; Richman JS; Safford MM J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28847913 [TBL] [Abstract][Full Text] [Related]
40. Cardiovascular Risk in HIV-Infected and Uninfected Postmenopausal Minority Women: Use of the Framingham Risk Score. Cortés YI; Reame N; Zeana C; Jia H; Ferris DC; Shane E; Yin MT J Womens Health (Larchmt); 2017 Mar; 26(3):241-248. PubMed ID: 27611626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]